Third article in Paolo's Biotech Notes series. PDF attached and uploaded. Additionally, Paolo has provided a relevant timely article. ContraFect Corp (CFRX) has a promising pipeline with a potential ...

Marinomed Biotech AG resumes Nice & Green Convertible Notes Funding Program with reduced volume 17.10.2023 / 07:45 CET/CEST The issuer is solely responsible for the content of this announcement.